Posted by Michael Wonder on 10 Mar 2021
Australia’s Therapeutic Goods Administration approves Feraccru to treat iron deficiency with or without anaemia in adults
9 March 2021 - Shield Therapeutics notes that Australia’s Therapeutic Goods Administration has registered Feraccru in the Australian Register of Therapeutic Goods to treat iron deficiency with or without anaemia in adults.
Feraccru is already approved in the UK, European Union, Switzerland and United States for the treatment of iron deficiency with or without anaemia in adults.
